FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Israel

Research Profile

Anatomy

Living Beings

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Cell Differentiation

Genes & Molecular Sequences

Oncogenes

Co-author Network

Publications

TOP 3
Paula Kuzontkoski; Mary Jo Mulligan-Kehoe; B T Harris; Mark Israel
Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.
Giles E Duffield; Nathan Watson; Akio Mantani; Stuart N Peirson; Maricela Robles-Murguia; Jennifer J Loros; Mark Israel; Jay C Dunlap
A role for Id2 in regulating photic entrainment of the mammalian circadian system.
Matthew C Havrda; Brent T Harris; Akio Mantani; Nora M Ward; Brenton R Paolella; Verginia C Cuzon; Hermes H Yeh; Mark Israel
Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Israel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Paula Kuzontkoski; Mary Jo Mulligan-Kehoe; B T Harris; Mark Israel
Inhibitor of DNA binding-4 promotes angiogenesis and growth of glioblastoma multiforme by elevating matrix GLA levels.
Oncogene 2010;29(26):3793-802.
2009: Giles E Duffield; Nathan Watson; Akio Mantani; Stuart N Peirson; Maricela Robles-Murguia; Jennifer J Loros; Mark Israel; Jay C Dunlap
A role for Id2 in regulating photic entrainment of the mammalian circadian system.
Current biology : CB 2009;19(4):297-304.
2008: Matthew C Havrda; Brent T Harris; Akio Mantani; Nora M Ward; Brenton R Paolella; Verginia C Cuzon; Hermes H Yeh; Mark Israel
Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(52):14074-86.
2008: Molly A Harris; Hyuna Yang; Benjamin E Low; Joydeep Mukherjee; Joydeep Mukherje; Abhijit Guha; Roderick T Bronson; Leonard D Shultz; Mark Israel; Kyuson Yun
Cancer stem cells are enriched in the side population cells in a mouse model of glioma.
Cancer research 2008;68(24):10051-9.
2008: Yasuyuki Hitoshi; Brent T Harris; Huan Liu; Brian Popko; Mark Israel
Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord.
Cancer research 2008;68(20):8507-15.
2008: Yu Liang; Maximilian Diehn; Andrew W Bollen; Mark Israel; Nalin Gupta
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment.
Journal of neuro-oncology 2008;86(2):133-41.
2007: Arti Gaur; David Jewell; Yu Liang; Dana Ridzon; Jason Moore; Caifu Chen; Victor Ambros; Mark Israel
Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
Cancer research 2007;67(6):2456-68.
2007: David M Reif; Mark Israel; Jason Moore
Exploratory Visual Analysis of statistical results from microarray experiments comparing high and low grade glioma.
Cancer informatics 2007;5():19-24.
2005: Tsuyoshi Tada; John Bang Nguyen; Yasuyuki Hitoshi; Nathan Watson; Jeffrey F Dunn; Shinji Ohara; Satoshi Nagano; Ken-ichiro Kosai; Mark Israel
Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirus.
Neurological research 2005;27(4):378-86.
2005: Yu Liang; Maximilian Diehn; Nathan Watson; Andrew W Bollen; Kenneth Aldape; M Kelly Nicholas; Kathleen R Lamborn; Mitchel S Berger; David Botstein; Patrick O Brown; Mark Israel
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(16):5814-9.
2004: Kyuson Yun; Akio Mantani; Sonia Garel; John Rubenstein; Mark Israel
Id4 regulates neural progenitor proliferation and differentiation in vivo.
Development (Cambridge, England) 2004;131(21):5441-8.
2004: Daniel J Murphy; Lamorna Brown Swigart; Mark Israel; Gerard I Evan
Id2 is dispensable for Myc-induced epidermal neoplasia.
Molecular and cellular biology 2004;24(5):2083-90.
2003: William A Weiss; Michael J Burns; Christopher S Hackett; Kenneth Aldape; John R Hill; Hiroko Kuriyama; Nagato Kuriyama; Nadezhda Milshteyn; Tim Roberts; Michael F Wendland; Ronald A DePinho; Mark Israel
Genetic determinants of malignancy in a mouse model for oligodendroglioma.
Cancer research 2003;63(7):1589-95.
2003: Zhilan Hu; Jeannette Bonifas; Geraldine Aragon; Levy Kopelovich; Yu Liang; Shoichiro Ohta; Mark Israel; David R Bickers; Michelle Aszterbaum; Ervin H Epstein
Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors.
Cancer research 2003;63(5):923-8.
2002: Peter J Houghton; Peter Charles Adamson; Susan Blaney; Howard A Fine; Richard Gorlick; Michelle Haber; Lee Helman; Steve Hirschfeld; Melinda G Hollingshead; Mark Israel; Richard B Lock; John M Maris; Glenn Merlino; Wendy Patterson; Charles Patrick Reynolds; Kevin Shannon; Alice L Yu; John Yu; Malcolm A Smith
Testing of new agents in childhood cancer preclinical models: meeting summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3646-57.
2002: William A Weiss; Mark Israel; Charles S Cobbs; Eric C Holland; C David James; David N Louis; Cheryl Marks; Andrea I McClatchey; Tim Roberts; Terry Van Dyke; Cynthia Wetmore; Ing-Ming Chiu; Marco Giovannini; Abhijit Guha; Robert J Higgins; Silvia Marino; Ivan Radovanovic; Karlyne M Reilly; Kenneth Aldape
Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
Oncogene 2002;21(49):7453-63.
2002: Robert C Brasch; Axel Gossmann; Thomas H Helbich; Nagato Kuriyama; Timothy P L Roberts; David M Shames; Nicholas van Bruggen; Michael F Wendland; Mark Israel
Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition?
Academic radiology 2002;9 Suppl 2():S326-7.
2002: Nathalie A Lokker; Carol M Sullivan; Stanley J Hollenbach; Mark Israel; Neill A Giese
Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Cancer research 2002;62(13):3729-35.
2002: Hiroko Kuriyama; Kathleen R Lamborn; Judith R O'Fallon; Nancy L Iturria; Thomas Sebo; Paul L Schaefer; Bernd W Scheithauer; Jan C Buckner; Nagato Kuriyama; Robert B Jenkins; Mark Israel
Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.
Neuro-oncology 2002;4(3):179-86.
2002: Tsuyoshi Tada; Mike Wendland; Nathan Watson; Nagato Kuriyama; Hiroko Kuriyama; Tim Roberts; Michael Burns; William Weiss; Mark Israel
A head holder for magnetic resonance imaging that allows the stereotaxic alignment of spontaneously occurring intracranial mouse tumors.
Journal of neuroscience methods 2002;116(1):1-7.
2002: Axel Gossmann; Thomas H Helbich; Nagato Kuriyama; Susanne Ostrowitzki; Timothy P L Roberts; David M Shames; Nicholas van Bruggen; Michael F Wendland; Mark Israel; Robert C Brasch
Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme.
Journal of magnetic resonance imaging : JMRI 2002;15(3):233-40.
2001: Fred G Barker; ML Simmons; Susan M Chang; Michael D Prados; David A Larson; Penny K Sneed; William M Wara; Mitchel S Berger; P Chen; Mark Israel; Kenneth Aldape
EGFR overexpression and radiation response in glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2001;51(2):410-8.
2001: W Hamel; D Zirkel; H M Mehdorn; M Westphal; Mark Israel
(E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
Cancer gene therapy 2001;8(5):388-96.
2001: David S Rickman; R Tyagi; XX Zhu; Miroslav P Bobek; S Song; Mila Blaivas; David E Misek; Mark Israel; David M Kurnit; Donald A Ross; Philip Kish; Samir M Hanash
The gene for the axonal cell adhesion molecule TAX-1 is amplified and aberrantly expressed in malignant gliomas.
Cancer research 2001;61(5):2162-8.
2001: Nagato Kuriyama; Hiroko Kuriyama; CM Julin; Kathleen R Lamborn; Mark Israel
Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Cancer research 2001;61(5):1805-9.
2001: ML Simmons; Kathleen R Lamborn; M Takahashi; P Chen; Mark Israel; Mitchel S Berger; Tony E Godfrey; Janice M Nigro; Michael Prados; S Chang; F G Barker; Kenneth Aldape
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
Cancer research 2001;61(3):1122-8.
2000: Nagato Kuriyama; H Kuriyama; CM Julin; Kathleen R Lamborn; Mark Israel
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy.
Human gene therapy 2000;11(16):2219-30.
2000: Carola Biederer; Stefan Ries; M Moser; M Florio; Mark Israel; Frank McCormick; R Buettner
The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development.
The Journal of biological chemistry 2000;275(34):26245-51.
2000: PJ Andres-Barquin; MC Hernandez; Mark Israel
Id genes in nervous system development.
Histology and histopathology 2000;15(2):603-18.
2000: Mary Janatpour; Michael McMaster; Olga Genbacev; Yan Zhou; Jian-Yun Dong; JC Cross; Mark Israel; Susan J Fisher
Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration.
Development (Cambridge, England) 2000;127(3):549-58.
2000: Hui-Kuo G Shu; CM Julin; F Furman; Garret Yount; Daphne A Haas-Kogan; Mark Israel
Overexpression of E2F1 in glioma-derived cell lines induces a p53-independent apoptosis that is further enhanced by ionizing radiation.
Neuro-oncology 2000;2(1):16-21.
2000: M Hernandez; PJ Andres-Barquin; Mark Israel
Assignment of the ectodermal-neural cortex 1 gene (Enc1) to mouse chromosome band 13D1 by fluorescence in situ hybridization.
Cytogenetics and cell genetics 2000;89(3-4):158-9.
1999: H Maruyama; Jörg Kleeff; S Wildi; Helmut Friess; Markus W Büchler; Mark Israel; Murray Korc
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.
The American journal of pathology 1999;155(3):815-22.
1999: Rhoda M Alani; Jens Hasskarl; Miranda Grace; MC Hernandez; Mark Israel; Karl Münger
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(17):9637-41.
1999: J R Hill; Nagato Kuriyama; Hiroko Kuriyama; Mark Israel
Molecular genetics of brain tumors.
Archives of neurology 1999;56(4):439-41.
1999: Mark Israel; MC Hernandez; M Florio; PJ Andres-Barquin; Akio Mantani; J H Carter; CM Julin
Id gene expression as a key mediator of tumor cell biology.
Cancer research 1999;59(7 Suppl):1726s-1730s.
1999: Garret Yount; K S Levine; H Kuriyama; Daphne A Haas-Kogan; Mark Israel
Fas (APO-1/CD95) signaling pathway is intact in radioresistant human glioma cells.
Cancer research 1999;59(6):1362-5.
1999: PJ Andres-Barquin; MC Hernandez; Mark Israel
Id4 expression induces apoptosis in astrocytic cultures and is down-regulated by activation of the cAMP-dependent signal transduction pathway.
Experimental cell research 1999;247(2):347-55.
1999: Daphne A Haas-Kogan; S S Kogan; Garret Yount; J Hsu; M Haas; Dennis F Deen; Mark Israel
p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.
International journal of radiation oncology, biology, physics 1999;43(2):399-403.
1999: MC Hernandez; PJ Andres-Barquin; W L Kuo; Mark Israel
Assignment of the ectodermal-neural cortex 1 gene (ENC1) to human chromosome band 5q13 by in situ hybridization.
Cytogenetics and cell genetics 1999;87(1-2):89-90.
1999: Mary Janatpour; Manuel Utset; JC Cross; J Rossant; Jian-Yun Dong; Mark Israel; Susan J Fisher
A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation.
Developmental genetics 1999;25(2):146-57.
1998: PJ Andres-Barquin; MC Hernandez; Mark Israel
Injury selectively down-regulates the gene encoding for the Id4 transcription factor in primary cultures of forebrain astrocytes.
Neuroreport 1998;9(18):4075-80.
1998: Hui-Kuo G Shu; M M Kim; Ping Chen; F Furman; CM Julin; Mark Israel
The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14453-8.
1998: Akio Mantani; MC Hernandez; W L Kuo; Mark Israel
The mouse Id2 and Id4 genes: structural organization and chromosomal localization.
Gene 1998;222(2):229-35.
1998: R H Haslam; K R Lamborn; Lawrence E Becker; Mark Israel
Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma.
Journal of pediatric hematology/oncology 1998;20(6):520-7.
1998: Garret Yount; Daphne A Haas-Kogan; K S Levine; Kenneth Aldape; Mark Israel
Ionizing radiation inhibits chemotherapy-induced apoptosis in cultured glioma cells: implications for combined modality therapy.
Cancer research 1998;58(17):3819-25.
1998: Jörg Kleeff; Toshiyuki Ishiwata; Helmut Friess; Markus W Büchler; Mark Israel; Murray Korc
The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer.
Cancer research 1998;58(17):3769-72.
1998: M Florio; MC Hernandez; H Yang; Hui-Kuo G Shu; J L Cleveland; Mark Israel
Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
Molecular and cellular biology 1998;18(9):5435-44.
1998: MC Hernandez; PJ Andres-Barquin; I Holt; Mark Israel
Cloning of human ENC-1 and evaluation of its expression and regulation in nervous system tumors.
Experimental cell research 1998;242(2):470-7.
1998: Susanne Ostrowitzki; J Fick; Timothy P L Roberts; Michael F Wendland; Kenneth Aldape; Jeffry S Mann; Mark Israel; Robert C Brasch
Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.
Journal of magnetic resonance imaging : JMRI 1998;8(4):799-806.
1997: MC Hernandez; PJ Andres-Barquin; S Martinez; Alessandro Bulfone; John L R Rubenstein; Mark Israel
ENC-1: a novel mammalian kelch-related gene specifically expressed in the nervous system encodes an actin-binding protein.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(9):3038-51.
1997: PJ Andres-Barquin; MC Hernandez; T E Hayes; R D McKay; Mark Israel
Id genes encoding inhibitors of transcription are expressed during in vitro astrocyte differentiation and in cell lines derived from astrocytic tumors.
Cancer research 1997;57(2):215-20.
1997: Fred G Barker; Ping Chen; F Furman; Kenneth Aldape; Michael S Edwards; Mark Israel
P16 deletion and mutation analysis in human brain tumors.
Journal of neuro-oncology 1997;31(1-2):17-23.
1996: T Rich; P Chen; F Furman; N Huynh; Mark Israel
RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin.
Gene 1996;180(1-2):125-30.
1996: W Hamel; Paul Dazin; Mark Israel
Adaptation of a simple flow cytometric assay to identify different stages during apoptosis.
Cytometry 1996;25(2):173-81.
1996: Daphne A Haas-Kogan; Garret Yount; M Haas; D Levi; S S Kogan; L Hu; C Vidair; Dennis F Deen; William C Dewey; Mark Israel
p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma.
International journal of radiation oncology, biology, physics 1996;36(1):95-103.
1996: MC Hernandez; PJ Andres-Barquin; Mark Israel
Molecular cloning of the cDNA encoding a helix-loop-helix protein, mouse ID1B: tissue-specific expression of ID1A and ID1B genes.
Biochimica et biophysica acta 1996;1308(1):28-30.
1996: Charles S Cobbs; D S Levi; Kenneth Aldape; Mark Israel
Manganese superoxide dismutase expression in human central nervous system tumors.
Cancer research 1996;56(14):3192-5.
1996: W Hamel; Lucia Magnelli; V P Chiarugi; Mark Israel
Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells.
Cancer research 1996;56(12):2697-702.
1996: A Ishiguro; K S Spirin; Masaaki Shiohara; A Tobler; Adrian F Gombart; Mark Israel; J D Norton; H Phillip Koeffler
Id2 expression increases with differentiation of human myeloid cells.
Blood 1996;87(12):5225-31.
1996: Anna Lasorella; A Iavarone; Mark Israel
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins.
Molecular and cellular biology 1996;16(6):2570-8.
1996: N Gupta; R Vij; D A Haas-Kogan; Mark Israel; Dennis F Deen; William F Morgan
Cytogenetic damage and the radiation-induced G1-phase checkpoint.
Radiation research 1996;145(3):289-98.
1996: Garret Yount; Daphne A Haas-Kogan; C A Vidair; M Haas; William C Dewey; Mark Israel
Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.
Cancer research 1996;56(3):500-6.
1995: J Fick; F G Barker; Paul Dazin; EM Westphale; E C Beyer; Mark Israel
The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(24):11071-5.
1995: F G Barker; Mark Israel
The molecular biology of brain tumors.
Neurologic clinics 1995;13(4):701-21.
1995: Anna Lasorella; A Iavarone; Mark Israel
Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
Cancer research 1995;55(20):4711-6.
1995: S Dee; D A Haas-Kogan; Mark Israel
Inactivation of p53 is associated with decreased levels of radiation-induced apoptosis in medulloblastoma cell lines.
Cell death and differentiation 1995;2(4):267-75.
1995: S Jensen; D C Paderanga; P Chen; K Olson; M Edwards; A Iavorone; Mark Israel; Kevin Shannon
Molecular analysis at the NF1 locus in astrocytic brain tumors.
Cancer 1995;76(4):674-7.
1995: P Chen; A Iavarone; J Fick; M Edwards; Michael Prados; Mark Israel
Constitutional p53 mutations associated with brain tumors in young adults.
Cancer genetics and cytogenetics 1995;82(2):106-15.
1995: W Zhu; J Dahmen; Alessandro Bulfone; M Rigolet; MC Hernandez; W L Kuo; Luis Puelles; John L R Rubenstein; Mark Israel
Id gene expression during development and molecular cloning of the human Id-1 gene.
Brain research. Molecular brain research 1995;30(2):312-26.
1995: Charles S Cobbs; Jay E Brenman; Kenneth Aldape; David S Bredt; Mark Israel
Expression of nitric oxide synthase in human central nervous system tumors.
Cancer research 1995;55(4):727-30.
1995: Daphne A Haas-Kogan; S C Kogan; D Levi; Paul Dazin; A T'Ang; Yuen-Kai Fung; Mark Israel
Inhibition of apoptosis by the retinoblastoma gene product.
The EMBO journal 1995;14(3):461-72.
1994: J Fick; Mark Israel
Gene therapy for diseases of the nervous system.
The Western journal of medicine 1994;161(3):260-3.
1994: A Iavarone; P Garg; Anna Lasorella; J Hsu; Mark Israel
The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.
Genes & development 1994;8(11):1270-84.
1994: B J Roseman; A Bollen; J Hsu; K Lamborn; Mark Israel
Annexin II marks astrocytic brain tumors of high histologic grade.
Oncology research 1994;6(12):561-7.
1993: Dennis F Deen; A Chiarodo; E A Grimm; John R Fike; Mark Israel; L E Kun; Victor Levin; L J Marton; R J Packer; A E Pegg
Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.
Journal of neuro-oncology 1993;16(3):243-72.
1993: Mark Israel
Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma.
Cancer 1993;71(10 Suppl):3310-3.
1993: Michael P Link; J Stevens; S H Friend; Mark Israel; Alfred G Knudson; Paul M Sondel
Laboratory-clinical interface.
Cancer 1993;71(10 Suppl):3219-21.
1993: Mark Israel
Molecular approaches to cancer therapy.
Advances in cancer research 1993;61():57-85.
1992: S A Reeves; C Chavez-Kappel; R Davis; Mark L Rosenblum; Mark Israel
Developmental regulation of annexin II (Lipocortin 2) in human brain and expression in high grade glioma.
Cancer research 1992;52(24):6871-6.
1992: M J Cooper; S M Steinberg; J Chatten; A E Evans; Mark Israel
Plasticity of neuroblastoma tumor cells to differentiate along a fetal adrenal ganglionic lineage predicts for improved patient survival.
The Journal of clinical investigation 1992;90(6):2402-8.
1992: R G Collum; Peter E Fisher; M Datta; S Mellis; C Thiele; K Huebner; C M Croce; Mark Israel; T Theil; Tarik Möröy
A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system.
Nucleic acids research 1992;20(18):4919-25.
1992: Jeffrey M Friedman; M Vitale; J Maimon; Mark Israel; M E Horowitz; B S Schneider
Expression of the cholecystokinin gene in pediatric tumors.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):5819-23.
1992: A Iavarone; K K Matthay; T M Steinkirchner; Mark Israel
Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(9):4207-9.
1992: Mark Israel
Rational approaches to breaching the blood-brain barrier.
The Western journal of medicine 1992;156(3):318-9.
1992: J Biggs; E V Murphy; Mark Israel
A human Id-like helix-loop-helix protein expressed during early development.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(4):1512-6.
1992: O M el-Badry; Mark Israel
Growth regulation of human neuroblastoma.
Cancer treatment and research 1992;63():105-28.
1991: Mark Israel
Molecular origins of pediatric embryonal tumors.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1991;3(5):193-4.
1991: O M El-Badry; Lee Helman; J Chatten; S M Steinberg; A E Evans; Mark Israel
Insulin-like growth factor II-mediated proliferation of human neuroblastoma.
The Journal of clinical investigation 1991;87(2):648-57.
1991: T Kidowaki; Carol Jeanne Thiele; H K Kleinman; Mark Israel
Matrix proteins induce neuroblastoma cell differentiation without altering cell growth.
Pathobiology : journal of immunopathology, molecular and cellular biology 1991;59(5):316-23.
1991: M J Cooper; Grover M Hutchins; P S Cohen; Lee Helman; Mark Israel
Neuroblastoma cell lines mimic chromaffin neuroblast maturation.
Progress in clinical and biological research 1991;366():343-50.
1990: P S Cohen; M J Cooper; Lee Helman; Carol Jeanne Thiele; Robert C Seeger; Mark Israel
Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.
Cancer research 1990;50(18):6055-61.
1990: M J Cooper; Grover M Hutchins; Mark Israel
Histogenesis of the human adrenal medulla. An evaluation of the ontogeny of chromaffin and nonchromaffin lineages.
The American journal of pathology 1990;137(3):605-15.
1990: M J Cooper; Grover M Hutchins; R J Mennie; Mark Israel
Beta 2-microglobulin expression in human embryonal neuroblastoma reflects its developmental regulation.
Cancer research 1990;50(12):3694-700.
1990: M J Cooper; Grover M Hutchins; P S Cohen; Lee Helman; R J Mennie; Mark Israel
Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(4):149-59.
1990: Mark Israel
Molecular approaches to oncologic pathology.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1990;2(3):84-6.
1990: Lee Helman; N Sack; S E Plon; Mark Israel
The sequence of an adrenal specific human cDNA, pG2.
Nucleic acids research 1990;18(3):685.
1989: D E Feltner; M Cooper; J Weber; Mark Israel; Carol Jeanne Thiele
Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(12):4292-9.
1989: Lee Helman; P S Cohen; S D Averbuch; M J Cooper; HR Keiser; Mark Israel
Neuropeptide Y expression distinguishes malignant from benign pheochromocytoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1720-5.
1989: R V LaRocca; Mark L Rosenblum; B Westermark; Mark Israel
Patterns of proto-oncogene expression in human glioma cell lines.
Journal of neuroscience research 1989;24(1):97-106.
1989: O M El-Badry; J A Romanus; Lee Helman; M J Cooper; Matthew M Rechler; Mark Israel
Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
The Journal of clinical investigation 1989;84(3):829-39.
1989: S A Reeves; Lee Helman; A Allison; Mark Israel
Molecular cloning and primary structure of human glial fibrillary acidic protein.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(13):5178-82.
1989: A Veillette; J O'Shaughnessy; ID Horak; Mark Israel; D Yee; Neal Rosen; D J Fujita; Hsing-Jien Kung; J L Biedler; J B Bolen
Coordinate alteration of pp60c-src abundance and c-src RNA expression in human neuroblastoma variants.
Oncogene 1989;4(4):421-7.
1989: Mark Israel
Pediatric oncology: model tumors of unparalleled import.
Journal of the National Cancer Institute 1989;81(6):404-8.
1989: P S Cohen; Mark Israel
Basic molecular biology for the pediatric hematologist/oncologist.
The American journal of pediatric hematology/oncology 1989;11(4):467-80.
1988: Carol Jeanne Thiele; L A Deutsch; Mark Israel
The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Oncogene 1988;3(3):281-8.
1988: Mark Israel
Molecular pathology: retrospective archival analyses.
Laboratory investigation; a journal of technical methods and pathology 1988;59(3):297-9.
1988: Lee Helman; T G Ahn; Michael Levine; A Allison; P S Cohen; M J Cooper; D V Cohn; Mark Israel
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA.
The Journal of biological chemistry 1988;263(23):11559-63.
1988: Lee Helman; Adi F Gazdar; J G Park; P S Cohen; J D Cotelingam; Mark Israel
Chromogranin A expression in normal and malignant human tissues.
The Journal of clinical investigation 1988;82(2):686-90.
1988: C McKeon; Carol Jeanne Thiele; R A Ross; M Kwan; Timothy Triche; J S Miser; Mark Israel
Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.
Cancer research 1988;48(15):4307-11.
1988: Adi F Gazdar; Lee Helman; Mark Israel; E K Russell; RI Linnoila; James L Mulshine; H M Schuller; J G Park
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Cancer research 1988;48(14):4078-82.
1988: P S Cohen; Robert C Seeger; Timothy Triche; Mark Israel
Detection of N-myc gene expression in neuroblastoma tumors by in situ hybridization.
The American journal of pathology 1988;131(3):391-7.
1988: Carol Jeanne Thiele; P S Cohen; Mark Israel
Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation.
Molecular and cellular biology 1988;8(4):1677-83.
1988: Carol Jeanne Thiele; L Cazenave; J B Bolen; Mark Israel
Developmentally regulated genes in neuroblastoma.
Progress in clinical and biological research 1988;271():185-94.
1988: Carol Jeanne Thiele; Mark Israel
Regulation of N-myc expression is a critical event controlling the ability of human neuroblasts to differentiate.
Experimental cell biology 1988;56(6):321-33.
1988: M J Cooper; Lee Helman; A E Evans; S Swamy; Daniel O'Connor; L Helson; Mark Israel
Chromogranin A expression in childhood peripheral neuroectodermal tumors.
Progress in clinical and biological research 1988;271():175-84.
1987: C R Fairchild; S Percy Ivy; C S Kao-Shan; J Whang-Peng; N Rosen; Mark Israel; Peter W Melera; Kenneth H Cowan; M E Goldsmith
Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.
Cancer research 1987;47(19):5141-8.
1987: Carol Jeanne Thiele; C McKeon; Timothy Triche; R A Ross; Charles Patrick Reynolds; Mark Israel
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system.
The Journal of clinical investigation 1987;80(3):804-11.
1987: N Rosen; Mark Israel
Genetic abnormalities as biological tumor markers.
Seminars in oncology 1987;14(2):213-31.
1987: Lee Helman; Carol Jeanne Thiele; W M Linehan; Barry D Nelkin; Stephen B Baylin; Mark Israel
Molecular markers of neuroendocrine development and evidence of environmental regulation.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(8):2336-9.
1987: Carol Jeanne Thiele; J Whang-Peng; C S Kao-Shan; J Miser; Mark Israel
Translocation of c-sis protooncogene in peripheral neuroepithelioma.
Cancer genetics and cytogenetics 1987;24(1):119-28.
1987: Mark Israel; Lee Helman; J Miser
Patterns of proto-oncogene expression: a novel approach to the development of tumor markers.
Important advances in oncology 1987;():87-104.
1986: N Rosen; J B Bolen; A M Schwartz; P Cohen; V DeSeau; Mark Israel
Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues.
The Journal of biological chemistry 1986;261(29):13754-9.
1986: Neal Rosen; Charles Patrick Reynolds; Carol Jeanne Thiele; J L Biedler; Mark Israel
Increased N-myc expression following progressive growth of human neuroblastoma.
Cancer research 1986;46(8):4139-42.
1986: Constance A Griffin; C McKeon; Mark Israel; A Gegonne; J Ghysdael; D Stehelin; E C Douglass; A E Green; B S Emanuel
Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(16):6122-6.
1986: J B Bolen; K Cary; A Scheller; C Basilico; Mark Israel; C Prives
A subclass of polyomavirus middle tumor antigen binds to DNA cellulose.
Journal of virology 1986;58(1):157-64.
1986: J Whang-Peng; Timothy Triche; Turid Knutsen; J Miser; S Kao-Shan; S Tsai; Mark Israel
Cytogenetic characterization of selected small round cell tumors of childhood.
Cancer genetics and cytogenetics 1986;21(3):185-208.
1986: Mark Israel
The evolution of clinical molecular genetics. Neuroblastoma as a model tumor.
The American journal of pediatric hematology/oncology 1986;8(2):163-72.
1986: B S Emanuel; P C Nowell; C McKeon; C M Croce; Mark Israel
Translocation breakpoint mapping: molecular and cytogenetic studies of chromosome 22.
Cancer genetics and cytogenetics 1986;19(1-2):81-92.
1986: S Amini; A M Lewis; Mark Israel; J S Butel; J B Bolen
Analysis of pp60c-src protein kinase activity in hamster embryo cells transformed by simian virus 40, human adenoviruses, and bovine papillomavirus 1.
Journal of virology 1986;57(1):357-61.
1985: J B Bolen; Neal Rosen; Mark Israel
Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7275-9.
1985: W Yonemoto; M Jarvis-Morar; Joan S Brugge; J B Bolen; Mark Israel
Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(14):4568-72.
1985: D R Kaplan; B Bockus; Thomas M Roberts; J Bolen; Mark Israel; B S Schaffhausen
Large-scale production of polyoma middle T antigen by using genetically engineered tumors.
Molecular and cellular biology 1985;5(7):1795-9.
1985: Carol Jeanne Thiele; Charles Patrick Reynolds; Mark Israel
Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.
Nature 1985;313(6001):404-6.
1985: L Donner; Timothy Triche; Mark Israel; Robert C Seeger; Charles Patrick Reynolds
A panel of monoclonal antibodies which discriminate neuroblastoma from Ewing's sarcoma, rhabdomyosarcoma, neuroepithelioma, and hematopoietic malignancies.
Progress in clinical and biological research 1985;175():347-66.
1985: Mark Israel; C Thiele; J Whang-Peng; C S Kao-Shan; Timothy Triche; J Miser
Peripheral neuroepithelioma: genetic analysis of tumor derived cell lines.
Progress in clinical and biological research 1985;175():161-70.
1985: J B Bolen; S E Fisher; K Chowdhury; T C Shan; J E Williams; C J Dawe; Mark Israel
A determinant of polyomavirus virulence enhances virus growth in cells of renal origin.
Journal of virology 1985;53(1):335-9.
1985: J B Bolen; Mark Israel
Middle tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with pp60c-src.
Journal of virology 1985;53(1):114-9.
1985: J B Bolen; A M Lewis; Mark Israel
Stimulation of pp60c-src tyrosyl kinase activity in polyoma virus-infected mouse cells is closely associated with polyoma middle tumor antigen synthesis.
Journal of cellular biochemistry 1985;27(2):157-67.
1984: J B Bolen; Mark Israel
In vitro association and phosphorylation of polyoma virus middle T antigen by cellular tyrosyl kinase activity.
The Journal of biological chemistry 1984;259(19):11686-94.
1984: J B Bolen; Carol Jeanne Thiele; Mark Israel; W Yonemoto; L A Lipsich; Joan S Brugge
Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.
Cell 1984;38(3):767-77.
1984: J Whang-Peng; Timothy Triche; Turid Knutsen; J Miser; E C Douglass; Mark Israel
Chromosome translocation in peripheral neuroepithelioma.
The New England journal of medicine 1984;311(9):584-5.
1983: J B Bolen; Mark Israel
Inhibition of polyoma virus middle T antigen-associated tyrosyl kinase activity by N-ethylmaleimide.
The Journal of biological chemistry 1983;258(24):15135-40.
1983: K Chowdhury; C F Garon; Mark Israel
Structural analysis of integrated polyomavirus DNA in a polyomavirus-induced hamster tumor cell line.
Journal of virology 1983;48(1):40-51.
1982: K Chowdhury; M L Meltzer; Mark Israel
Stability of polyoma DNA sequences and virus-coded proteins during tumor formation.
Journal of virology 1982;41(3):1000-6.
1982: K Tanaka; K Chowdhury; K S Chang; Mark Israel; Y Ito
Isolation and characterization of polyoma virus mutants which grow in murine embryonal carcinoma and trophoblast cells.
The EMBO journal 1982;1(12):1521-7.
1980: Peter M Howley; F Rentier-Delrue; Carole Heilman; M F Law; K Chowdhury; Mark Israel; K K Takemoto
Cloned human polyomavirus JC DNA can transform human amnion cells.
Journal of virology 1980;36(3):878-82.
1980: K Chowdhury; S E Light; C F Garon; Y Ito; Mark Israel
A cloned polyoma DNA fragment representing the 5' half of the early gene region is oncogenic.
Journal of virology 1980;36(2):566-74.
1980: Carole Heilman; M F Law; Mark Israel; Peter M Howley
Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences.
Journal of virology 1980;36(2):395-407.
1980: Mark Israel; Malcolm Martin; T Miyamura; K K Takemoto; D Rifkin; R Pollack
Phenotype of polyoma-induced hamster tumor cells lines.
Journal of virology 1980;35(1):252-5.
1980: Mark Israel; D F Vanderryn; M L Meltzer; Malcolm Martin
Characterization of polyoma viral DNA sequences in polyoma-induced hamster tumor cell lines.
The Journal of biological chemistry 1980;255(8):3798-805.
1980: J L Moore; K Chowdhury; Malcolm Martin; Mark Israel
Polyoma large tumor antigen is not required for tumorigenesis mediated by viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(3):1336-40.
1980: Mark Israel; K Chowdhury; J Ramseur; K Chandrasekaran; D F Vanderryn; Malcolm Martin
Tumorigenicity of polyoma virus in hamsters.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 1,():591-6.
1979: Mark Israel; H W Chan; Malcolm Martin; W P Rowe
Molecular cloning of polyoma virus DNA in Escherichia coli: oncogenicity testing in hamsters.
Science (New York, N.Y.) 1979;205(4411):1140-2.
1979: G L Hager; E H Chang; H W Chan; C F Garon; Mark Israel; Malcolm Martin; E M Scolnick; Douglas Lowy
Molecular cloning of the Harvey sarcoma virus closed circular DNA intermediates: initial structural and biological characterization.
Journal of virology 1979;31(3):795-809.
1979: Mark Israel; D T Simmons; S L Hourihan; W P Rowe; Malcolm Martin
Interrupting the early region of polyoma virus DNA enhances tumorigenicity.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(8):3713-6.
1979: Peter M Howley; Mark Israel; M F Law; Malcolm Martin
A rapid method for detecting and mapping homology between heterologous DNAs. Evaluation of polyomavirus genomes.
The Journal of biological chemistry 1979;254(11):4876-83.
1979: H W Chan; Mark Israel; C F Garon; W P Rowe; Malcolm Martin
Molecular cloning of polyoma virus DNA in Escherichia coli: lambda phage vector system.
Science (New York, N.Y.) 1979;203(4383):887-92.
1979: Mark Israel; H W Chan; W P Rowe; Malcolm Martin
Molecular cloning of polyoma virus DNA in Escherichia coli: plasmid vector system.
Science (New York, N.Y.) 1979;203(4383):883-7.
1979: Mark Israel; H W Chan; S L Hourihan; W P Rowe; Malcolm Martin
Biological activity of polyoma viral DNA in mice and hamsters.
Journal of virology 1979;29(3):990-6.
1978: Mark Israel; Malcolm Martin; K K Takemoto; Peter M Howley; S A Aaronson; D Solomon; G Khoury
Evaluation of normal and neoplastic human tissue for BK virus.
Virology 1978;90(2):187-96.
1978: Mark Israel; J C Byrne; Malcolm Martin
Biologic activity of oligomeric forms of SV40 DNA.
Virology 1978;87(2):239-46.
1975: Mark Israel; K Kuriyama; K Yoshikawa
Effect of ethanol administration on axoplasmic flow in the brain.
Neuropharmacology 1975;14(5-6):445-51.
1973: K Kuriyama; Mark Israel
Effect of ethanol administration on cyclic 3',5'-adenosine monophosphate metabolism in brain.
Biochemical pharmacology 1973;22(22):2919-22.
1972: Mark Israel; H Kimura; K Kuriyama
Changes in activity and hormonal sensitivity of brain adenyl cyclase following chronic ethanol administration.
Experientia 1972;28(11):1322-3.
1971: Mark Israel; K Kuriyama
Effect of in vivo ethanol administration on adenosinetriphosphatase activity of subcellular fractions of mouse brain and liver.
Life sciences. Pt. 2: Biochemistry, general and molecular biology 1971;10(10):591-9.